Jazz Pharmaceuticals
JAZZ
JAZZ
319 hedge funds and large institutions have $8.31B invested in Jazz Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 114 increasing their positions, 103 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
319
Holders Change
+13
Holders Change %
+4.25%
% of All Funds
7.97%
Holding in Top 10
11
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.27%
New
52
Increased
114
Reduced
103
Closed
37
Calls
$80.3M
Puts
$68.4M
Net Calls
+$11.8M
Net Calls Change
-$41.9M
Top Buyers
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$125M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$99.7M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$89.4M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$53.5M |
| 5 |
TCP
Tourbillon Capital Partners
New York
|
-$27.9M |
